These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22984200)

  • 1. Urology meeting highlights prostate, bladder cancers.
    Fillon M
    J Natl Cancer Inst; 2012 Sep; 104(18):1348-9. PubMed ID: 22984200
    [No Abstract]   [Full Text] [Related]  

  • 2. [Urologists introduce a new round of prostate specific antigen discussion].
    Aktuelle Urol; 2013 Jul; 44(4):257-8. PubMed ID: 23904120
    [No Abstract]   [Full Text] [Related]  

  • 3. New PSA guidelines discourage overscreening.
    Peres J
    J Natl Cancer Inst; 2012 Jan; 104(1):8-9. PubMed ID: 22173585
    [No Abstract]   [Full Text] [Related]  

  • 4. Prostate cancer: is the PSA test the answer?
    Berlin B
    N J Med; 1998 Mar; 95(3):53-5. PubMed ID: 16013148
    [No Abstract]   [Full Text] [Related]  

  • 5. States renewing attention to prostate cancer.
    Rossiter C
    NCSL Legisbrief; 2012 Sep; 20(36):1-2. PubMed ID: 23072022
    [No Abstract]   [Full Text] [Related]  

  • 6. Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era.
    Welch HG; Fisher ES; Gottlieb DJ; Barry MJ
    J Natl Cancer Inst; 2007 Sep; 99(18):1395-400. PubMed ID: 17848671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The National Board of Health and Welfare's guidelines for prostatic cancer care. PSA test screening--only for well-informed men].
    Bratt O; Damber JE; Kärvinge C; Malm T; Hensjö LO; Hyttsten E
    Lakartidningen; 2008 Feb 20-26; 105(8):524-8. PubMed ID: 18363292
    [No Abstract]   [Full Text] [Related]  

  • 8. Why prostate cancer screening is necessary.
    Witte MN; Lindaman BD; Rosinsky DE
    S D Med; 2015; Spec No():88-91. PubMed ID: 25985616
    [No Abstract]   [Full Text] [Related]  

  • 9. General adherence to guideline recommendations on initial diagnosis of bladder cancer in the United States and influencing factors.
    Karl A; Adejoro O; Saigal C; Konety B;
    Clin Genitourin Cancer; 2014 Aug; 12(4):270-7. PubMed ID: 24332507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commentary on association of clinical prostate and bladder cancers.
    Nieder AM
    J Urol; 2008 May; 179(5 Suppl):S6. PubMed ID: 18405754
    [No Abstract]   [Full Text] [Related]  

  • 11. [The prostate specific antigen: what can we learn from the American experience?].
    Zhao XJ
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3313-5. PubMed ID: 16409833
    [No Abstract]   [Full Text] [Related]  

  • 12. [Authorities in USA don't recommend screening for prostate cancer].
    Bratt O
    Lakartidningen; 2011 Nov 16-22; 108(46):2362. PubMed ID: 22468374
    [No Abstract]   [Full Text] [Related]  

  • 13. Prostate specific antigen and other markers for prostate cancer.
    Schröder FH
    J Urol; 2006 Apr; 175(4):1199-200. PubMed ID: 16515959
    [No Abstract]   [Full Text] [Related]  

  • 14. [Large part of Swedish men PSA tested for early prostatic cancer. Few aware of the disadvantages of the test].
    Bratt O; Grenabo L
    Lakartidningen; 2010 Feb 17-23; 107(7):432-5. PubMed ID: 20384075
    [No Abstract]   [Full Text] [Related]  

  • 15. A guide to a new prostate cancer tests.
    Johns Hopkins Med Lett Health After 50; 2014 May; 29(3):4-5. PubMed ID: 25097944
    [No Abstract]   [Full Text] [Related]  

  • 16. [Legal (liability) aspects of PSA determination].
    Mielke K
    Urologe A; 2006 Jun; 45(6):756-65. PubMed ID: 16788794
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?
    Rosser CJ; Parker A
    J Urol; 2005 Sep; 174(3):1154-5; author reply 1155-6. PubMed ID: 16094093
    [No Abstract]   [Full Text] [Related]  

  • 18. No one dies from prostate cancer?
    Chau D
    Arch Intern Med; 2006 Jul; 166(14):1525; author reply 1526. PubMed ID: 16864764
    [No Abstract]   [Full Text] [Related]  

  • 19. Measuring the importance of PSA velocity.
    Tuma RS
    J Natl Cancer Inst; 2011 Mar; 103(6):454-61. PubMed ID: 21393606
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessing risk: does this patient have prostate cancer?
    Carter HB
    J Natl Cancer Inst; 2006 Apr; 98(8):506-7. PubMed ID: 16622114
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.